Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: A randomized, controlled trial

Department of Pneumology, Hospital Mútua de Terrassa, Universitat Autònoma de Barcelona, Barcelona, Spain.
Journal of Hypertension (Impact Factor: 4.72). 10/2010; 28(10):2161-8. DOI: 10.1097/HJH.0b013e32833b9c63
Source: PubMed


This controlled trial assessed the effect of continuous positive airway pressure (CPAP) on blood pressure (BP) in patients with obstructive sleep apnea (OSA) and resistant hypertension (RH).
We evaluated 96 patients with resistant hypertension, defined as clinic BP at least 140/90 mmHg despite treatment with at least three drugs at adequate doses, including a diuretic. Patients underwent a polysomnography and a 24-h ambulatory BP monitoring (ABPM). They were classified as consulting room or ABPM-confirmed resistant hypertension, according to 24-h BP lower or higher than 125/80 mmHg. Patients with an apnea-hypopnea index at least 15 events/h (n = 75) were randomized to receive either CPAP added to conventional treatment (n = 38) or conventional medical treatment alone (n = 37). ABPM was repeated at 3 months. The main outcome was the change in systolic and diastolic BP.
Sixty-four patients completed the follow-up. Patients with ABPM-confirmed resistant hypertension treated with CPAP (n = 20), unlike those treated with conventional treatment (n = 21), showed a decrease in 24-h diastolic BP (-4.9 ± 6.4 vs. 0.1 ± 7.3 mmHg, P = 0.027). Patients who used CPAP > 5.8 h showed a greater reduction in daytime diastolic BP {-6.12 mmHg [confidence interval (CI) -1.45; -10.82], P = 0.004}, 24-h diastolic BP (-6.98 mmHg [CI -1.86; -12.1], P = 0.009) and 24-h systolic BP (-9.71 mmHg [CI -0.20; -19.22], P = 0.046). The number of patients with a dipping pattern significantly increased in the CPAP group (51.7% vs. 24.1%, P = 0.008).
In patients with resistant hypertension and OSA, CPAP treatment for 3 months achieves reductions in 24-h BP. This effect is seen in patients with ABPM-confirmed resistant hypertension who use CPAP more than 5.8 h.

Download full-text


Available from: Maria Jose Jurado, Sep 29, 2015
56 Reads
  • Source
    • "Moreover, it has been recently reported that neither clinic BP measurement (in the physician's office), nor home self-BP measurements (three morning and three evening BP measurements made by the patients at home) were sufficient to detect masked hypertension in OSA patients, justifying 24-h ABPM as the gold-standard to detect abnormal BP in OSA patients [15]. In addition, OSA is by far the leading cause of refractory hypertension [16] [17], and should be systematically investigated in this situation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cardiovascular autonomic control changes across sleep stages. Thus, blood pressure (BP), heart rate and peripheral vascular resistances progressively decrease in non rapid eye movement sleep. Any deterioration in sleep quality or quantity may be associated with an increase in nocturnal BP which could participate in the development or poor control of hypertension. In the present report, sleep problems/disorders, which impact either the sleep quality or quantity, are reviewed for their interaction with BP regulation and their potential association with prevalent or incident hypertension. Obstructive sleep apnea syndrome, sleep duration/deprivation, insomnia, restless legs syndrome and narcolepsy are successively reviewed. Obstructive sleep apnea is clearly associated with the development of hypertension that is only slightly reduced by continuous positive airway pressure treatment. Shorter and longer sleep durations are associated with prevalent or incident hypertension but age, gender, environmental exposures and ethnic disparities are clear confounders. Insomnia with objective short sleep duration, restless legs syndrome and narcolepsy may impact BP control, needing additional studies to establish their impact in the development of permanent hypertension. Addressing sleep disorders or sleep habits seems a relevant issue when considering the risk of developing hypertension or the control of pre-existent hypertension. Combined sleep problems may have potential synergistic deleterious effects.
    Sleep Medicine Reviews 12/2014; 18(6). DOI:10.1016/j.smrv.2014.03.003 · 8.51 Impact Factor
  • Source
    • "Statistics for each study Difference in means and 95% CI Logan 2003 Garcia 2007 Lozano 2010 Pedrosa 2013 Litvin 2013 Garcia 2013 Difference in means "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To systematically analyze the studies that have examined the effect of continuous positive airway pressure (CPAP) on blood pressure (BP) in patients with resistant hypertension and obstructive sleep apnea (OSA). Methods: Design - meta-analysis of observational studies and randomized controlled trials (RCTs) indexed in PubMed and Ovid (All Journals@Ovid). participants: individuals with resistant hypertension and OSA; interventions - CPAP treatment. Results: A total of six studies met the inclusion criteria for preintervention to postintervention analyses. The pooled estimates of mean changes after CPAP treatment for the ambulatory (24-h) SBP and DBP from six studies were -7.21 mmHg [95% confidence interval (CI): -9.04 to -5.38; P < 0.001; I² 58%) and -4.99 mmHg (95% CI: -6.01 to -3.96; P < 0.001; I² 31%), respectively. The pooled estimate of the ambulatory SBP and DBP from the four RCTs showed a mean net change of -6.74 mmHg [95% CI: -9.98 to -3.49; P < 0.001; I² 61%] and -5.94 mmHg (95% CI: -9.40 to -2.47; P = 0.001; I² 76%), respectively, in favor of the CPAP group. Conclusion: The pooled estimate shows a favorable reduction of BP with CPAP treatment in patients with resistant hypertension and OSA. The effects sizes are larger than those previously reported in patients with OSA without resistant hypertension.
    Journal of Hypertension 09/2014; 32(12). DOI:10.1097/HJH.0000000000000372 · 4.72 Impact Factor
  • Source
    • "2013 Randomized singlecenter control trial Resistant hypertension with no previous diagnosis of OSA Subjects who were older than 65 years or younger than 30 years, as well as those with other secondary causes of hypertension b 20 20 6 months Lozano L et al. [19] 2010 Randomized singlecenter control trial Patients aged between 18 and 80 with resistant hypertension Upper airway malformations, a history of poor treatment compliance and secondary causes of hypertension, including renal insufficiency (creatinine N "
    International Journal of Cardiology 04/2014; 175(1). DOI:10.1016/j.ijcard.2014.04.240 · 4.04 Impact Factor
Show more

Similar Publications